New York – September 10, 2026 -- Halper Sadeh LLC has launched an investigation into whether officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shareholders.

Law Firm Targets DexCom Governance Practices

The New York-based investor rights firm, operating out of One World Trade Center, is examining potential corporate misconduct at the continuous glucose monitoring device maker. Attorneys Daniel Sadeh and Zachary Halper are leading the inquiry.